These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32552709)

  • 1. Quantitative fragmented QRS has a good diagnostic value on myocardial fibrosis in hypertrophic obstructive cardiomyopathy based on clinical-pathological study.
    Bi X; Yang C; Song Y; Yuan J; Cui J; Hu F; Qiao S
    BMC Cardiovasc Disord; 2020 Jun; 20(1):298. PubMed ID: 32552709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragmented QRS on electrocardiography as a predictor of myocardial scar in patients with hypertrophic cardiomyopathy.
    Ratheendran AC; Subramanian M; Bhanu DK; Prabhu MA; Kannan R; Natarajan KU; Saritha Sekhar S; Thachathodiyil R; Harikrishnan MS; Pai PG
    Acta Cardiol; 2020 Feb; 75(1):42-46. PubMed ID: 30602338
    [No Abstract]   [Full Text] [Related]  

  • 3. Electrocardiographic QRS Fragmentation as a Marker for Myocardial Fibrosis in Hypertrophic Cardiomyopathy.
    Konno T; Hayashi K; Fujino N; Oka R; Nomura A; Nagata Y; Hodatsu A; Sakata K; Furusho H; Takamura M; Nakamura H; Kawashiri MA; Yamagishi M
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1081-7. PubMed ID: 26102305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiography based prediction of hypertrophy pattern and fibrosis amount in hypertrophic cardiomyopathy: comparative study with cardiac magnetic resonance imaging.
    Park CH; Chung H; Kim Y; Kim JY; Min PK; Lee KA; Yoon YW; Kim TH; Lee BK; Hong BK; Rim SJ; Kwon HM; Choi EY
    Int J Cardiovasc Imaging; 2018 Oct; 34(10):1619-1628. PubMed ID: 29728953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How are ECG parameters related to cardiac magnetic resonance images? Electrocardiographic predictors of left ventricular hypertrophy and myocardial fibrosis in hypertrophic cardiomyopathy.
    Dohy Z; Vereckei A; Horvath V; Czimbalmos C; Szabo L; Toth A; Suhai FI; Csecs I; Becker D; Merkely B; Vago H
    Ann Noninvasive Electrocardiol; 2020 Sep; 25(5):e12763. PubMed ID: 32329134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced myocardial septal function assessed by cardiac magnetic resonance feature tracking in patients with hypertrophic obstructive cardiomyopathy: associated with histological myocardial fibrosis and ventricular arrhythmias.
    Song Y; Bi X; Chen L; Yang K; Chen X; Dong Z; Wang J; Kong X; Zhao K; Wang H; Duru F; Lu M; Ma L; Qiao S; Zhao S
    Eur Heart J Cardiovasc Imaging; 2022 Jul; 23(8):1006-1015. PubMed ID: 35167663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of fragmented QRS complex to right ventricular fibrosis detected by late gadolinium enhancement cardiac magnetic resonance in adults with repaired tetralogy of fallot.
    Park SJ; On YK; Kim JS; Park SW; Yang JH; Jun TG; Kang IS; Lee HJ; Choe YH; Huh J
    Am J Cardiol; 2012 Jan; 109(1):110-5. PubMed ID: 21962997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy.
    Almaas VM; Haugaa KH; Strøm EH; Scott H; Smith HJ; Dahl CP; Geiran OR; Endresen K; Aakhus S; Amlie JP; Edvardsen T
    Heart; 2014 Apr; 100(8):631-8. PubMed ID: 24368281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.
    Moravsky G; Ofek E; Rakowski H; Butany J; Williams L; Ralph-Edwards A; Wintersperger BJ; Crean A
    JACC Cardiovasc Imaging; 2013 May; 6(5):587-96. PubMed ID: 23582356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragmented QRS complexes are not hallmarks of myocardial injury as detected by cardiac magnetic resonance imaging in patients with acute myocardial infarction.
    Ahn MS; Kim JB; Yoo BS; Lee JW; Lee JH; Youn YJ; Ahn SG; Kim JY; Lee SH; Yoon J; Choe KH
    Int J Cardiol; 2013 Oct; 168(3):2008-13. PubMed ID: 23336958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic predictors of myocardial fibrosis and apical hypertrophic cardiomyopathy.
    Tangwiwat C; Kaolawanich Y; Krittayaphong R
    Ann Noninvasive Electrocardiol; 2019 Mar; 24(2):e12612. PubMed ID: 30403441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of electrocardiographic changes and myocardial fibrosis in patients with hypertrophic cardiomyopathy detected by cardiac magnetic resonance imaging.
    Song BG; Yang HS; Hwang HK; Kang GH; Park YH; Chun WJ; Oh JH
    Clin Cardiol; 2013 Jan; 36(1):31-5. PubMed ID: 23070984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Appearance of Fragmented QRS as a Predictor of Ventricular Arrhythmic Events in Patients With Hypertrophic Cardiomyopathy.
    Ogura S; Nakamura K; Morita H; Toh N; Nakagawa K; Yoshida M; Watanabe A; Nishii N; Miyoshi T; Ito H
    Circ J; 2020 Feb; 84(3):487-494. PubMed ID: 32037379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-221 is a potential biomarker of myocardial hypertrophy and fibrosis in hypertrophic obstructive cardiomyopathy.
    Huang D; Chen Z; Wang J; Chen Y; Liu D; Lin K
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31868204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvascular Rarefaction and Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy.
    Tian H; Yang C; Song Y; Wang H; Yuan J; Cui J; Liu S; Hu F; Yang W; Jiang X; Qiao S
    Cardiology; 2018; 141(4):202-211. PubMed ID: 30820009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
    Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragmented QRS as a candidate marker for high-risk assessment in hypertrophic cardiomyopathy.
    Kang KW; Janardhan AH; Jung KT; Lee HS; Lee MH; Hwang HJ
    Heart Rhythm; 2014 Aug; 11(8):1433-40. PubMed ID: 24813377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Values of N-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin I for Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy.
    Zhang C; Liu R; Yuan J; Cui J; Hu F; Yang W; Zhang Y; Chen Y; Qiao S
    PLoS One; 2016; 11(1):e0146572. PubMed ID: 26765106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
    Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
    J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.